[go: up one dir, main page]

MX2010004509A - Formulaciones inyectables de accion prolongada. - Google Patents

Formulaciones inyectables de accion prolongada.

Info

Publication number
MX2010004509A
MX2010004509A MX2010004509A MX2010004509A MX2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A MX 2010004509 A MX2010004509 A MX 2010004509A
Authority
MX
Mexico
Prior art keywords
long acting
injectable formulations
acting injectable
endoparasites
animals
Prior art date
Application number
MX2010004509A
Other languages
English (en)
Inventor
Peter Andrew O'neill
Carolina Nunes Costa Corgozinho
Karla De Melo Lima
Jose Junior Maciel
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2010004509A publication Critical patent/MX2010004509A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen formulaciones inyectables de acción prolongada de lactonas macrocíclicas que comprenden un polímero de poliéster biológicamente aceptable y biodegradable en un sistema solvente para uso en el campo veterinario, especialmente para uso en el combate de ectoparásitos y endoparásitos en animales.
MX2010004509A 2007-10-25 2008-10-24 Formulaciones inyectables de accion prolongada. MX2010004509A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0705822-5A BRPI0705822A2 (pt) 2007-10-25 2007-10-25 formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
US9501508P 2008-09-08 2008-09-08
PCT/EP2008/064448 WO2009053466A1 (en) 2007-10-25 2008-10-24 Long acting injectable formulations

Publications (1)

Publication Number Publication Date
MX2010004509A true MX2010004509A (es) 2010-05-03

Family

ID=40297850

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004509A MX2010004509A (es) 2007-10-25 2008-10-24 Formulaciones inyectables de accion prolongada.

Country Status (9)

Country Link
US (1) US20110039794A1 (es)
EP (1) EP2211839A1 (es)
AR (1) AR069033A1 (es)
AU (1) AU2008316416A1 (es)
BR (2) BRPI0705822A2 (es)
CA (1) CA2702800A1 (es)
MX (1) MX2010004509A (es)
NZ (1) NZ584585A (es)
WO (1) WO2009053466A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013057222A2 (en) * 2011-10-18 2013-04-25 Institut National De La Recherche Agronomique Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
US10179173B2 (en) 2012-03-23 2019-01-15 Regents Of The University Of Minnesota Semi-solid delivery systems
AR094882A1 (es) 2013-02-26 2015-09-02 Zoetis Llc Selamectina para el tratamiento de las infestaciones por piojos de mar, composición
JP7447315B2 (ja) 2020-05-20 2024-03-11 インターベット インターナショナル ベー． フェー． 注射可能な医薬組成物及びその使用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP & DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
PT1063942E (pt) * 1998-03-19 2004-10-29 Merck & Co Inc Composicoes polimericas liquidas para libertacao controlada de substancias bioactivas
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
GB2386067A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
MXPA05012791A (es) * 2003-05-25 2006-02-22 Wang Yuwan Formulacion sostenida que contiene dimeticona.
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations

Also Published As

Publication number Publication date
WO2009053466A1 (en) 2009-04-30
CA2702800A1 (en) 2009-04-30
NZ584585A (en) 2012-08-31
BRPI0818258A2 (pt) 2019-09-24
AR069033A1 (es) 2009-12-23
AU2008316416A1 (en) 2009-04-30
EP2211839A1 (en) 2010-08-04
US20110039794A1 (en) 2011-02-17
BRPI0705822A2 (pt) 2009-06-23

Similar Documents

Publication Publication Date Title
ES2649340T3 (es) Administración de fármacos activados por hipoxia y agentes antiangiogénicos para el tratamiento del cáncer
MX2009005445A (es) Sistema de suministro para risperidona.
CY1119829T1 (el) Βιοαποικοδομησιμες συνθεσεις απελευθερωσης φαρμακου
MX2010004789A (es) Sistema de liberacion transdermica para hormonas y esteroides.
WO2008094834A3 (en) Multi-functional drug carriers
WO2008002434A3 (en) Medical devices for release of low solubility therapeutic agents
EP2213318A4 (en) DRUG SOLUTION DELIVERY SYSTEM AND DRUG SOLUTION ADMINISTRATION CANNULA
WO2008005176A3 (en) Electroactive polymer radiopaque marker
WO2008124735A3 (en) Multi-functional polyglutamate drug carriers
MX2009012781A (es) Formulaciones de transferencia sostenida de compuestos de risperidona.
BRPI0814759A2 (pt) Sistema de administração e notificação de medicamento específico de paciente
MX2010004222A (es) Formulaciones solidas de compuestos cristalinos.
WO2007103666A3 (en) Implantable medical endoprosthesis delivery systems
EP2313122A4 (en) MEDICAL ACTIVE COMPOSITION DEVICE
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
IL184552A0 (en) Devices, systems, and methods for medicament delivery
GB0817324D0 (en) Vaginal drug delivery system and method
EP1962906A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE ANTICREME AND AT LEAST ONE POLYMER
WO2010099292A3 (en) Biodegradable drug or other active delivery system
WO2009014827A3 (en) Medical devices comprising polymeric drug delivery systems with drug solubility gradients
MX2009012043A (es) Activador de celulas t citotoxicas que comprende agonista ep4.
WO2006097558A3 (es) Nanopartículas de quitosano y polientilenglicol como sistema de administración de moléculas biológicamente activas
LTPA2019508I1 (lt) Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui
EP1901796A4 (en) ACTIVE RELEASE SYSTEM
AP2011005687A0 (en) Sustained release drug delivery system.